{"id":975,"date":"2023-10-20T14:18:33","date_gmt":"2023-10-20T11:18:33","guid":{"rendered":"https:\/\/cidsr.md\/?page_id=975"},"modified":"2024-04-03T12:26:59","modified_gmt":"2024-04-03T09:26:59","slug":"studii-clinice","status":"publish","type":"page","link":"https:\/\/cidsr.md\/en\/portofolio\/studii-clinice\/","title":{"rendered":"Clinical studies","raw":"Clinical studies"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\nTitle<\/strong><\/td>\n\u00a0Period<\/strong><\/td>\n\u00a0Donor, Study Budget<\/strong><\/td>\n<\/tr>\n
1.<\/td>\nMedical abortion via telemedicine for women and adolescents in rural Moldova: breaking barriers with technology, Telemedicine abortion for women and girls in rural Moldova<\/a><\/td>\n2019-2021
\n<\/strong><\/td>\n		Grand Challenges Canada \u2013 The OPTions Initiative<\/a><\/td>\n<\/tr>\n
2.<\/td>\nSimplified medical abortion: a pilot demonstration project<\/a><\/td>\n2015-2016<\/td>\nGynuity Health Projects<\/a>,<\/td>\n<\/tr>\n
3.<\/td>\nMifepristone and Misoprostol versus Misoprostol alone for mid-trimester termination of pregnancy (14\u00a0– 21 weeks LMP): A randomized-controlled double-blinded trial<\/td>\n2011-2012<\/td>\nGynuity Health Projects<\/a><\/td>\n<\/tr>\n
4.<\/td>\nThe acceptability and feasibility of reducing the need for in-clinic follow-up for first trimester medical abortion in Moldova and Uzbekistan<\/td>\n2010-2011<\/td>\n\u00a0Gynuity Health Projects<\/a>,<\/td>\n<\/tr>\n
5.<\/td>\nUptake and acceptability of home-use of medical abortion<\/td>\n2009<\/td>\n\u00a0Gynuity Health Projects<\/a>,<\/td>\n<\/tr>\n
6.<\/td>\nMifepristone and Misoprostol versus Misoprostol alone for mid-trimester termination of pregnancy(14-21weeks)<\/td>\n2009<\/td>\n\u00a0Gynuity Health Projects<\/a>,<\/td>\n<\/tr>\n
7.<\/td>\nA randomized study of sublingual and buccal misoprostol administration following mifepristone 200 mg for abortion up to 63 days gestation<\/td>\n2007-2008<\/td>\n\u00a0Gynuity Health Projects<\/a><\/td>\n<\/tr>\n
8.<\/td>\nSublingual misoprostol following mifepristone 200 mg for abortion up to 63 days gestation<\/td>\n\u00a02007<\/td>\n\u00a0Gynuity Health Projects<\/a><\/td>\n<\/tr>\n
9.<\/td>\nMisoprostol for treatment of incomplete abortion<\/td>\n\u00a02005<\/td>\nGynuity Health Projects<\/a><\/td>\n<\/tr>\n
10.<\/td>\nAcceptability and feasibility of medical abortion in law resources settings<\/td>\n\u00a02004<\/td>\nGynuity Health Projects<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false,"raw":"\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
<\/td>\r\nTitle<\/strong><\/td>\r\n\u00a0Period<\/strong><\/td>\r\n\u00a0Donor, Study Budget<\/strong><\/td>\r\n<\/tr>\r\n
1.<\/td>\r\nMedical abortion via telemedicine for women and adolescents in rural Moldova: breaking barriers with technology, Telemedicine abortion for women and girls in rural Moldova<\/a><\/td>\r\n2019-2021\r\n<\/strong><\/td>\r\nGrand Challenges Canada \u2013 The OPTions Initiative<\/a><\/td>\r\n<\/tr>\r\n
2.<\/td>\r\nSimplified medical abortion: a pilot demonstration project<\/a><\/td>\r\n2015-2016<\/td>\r\nGynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
3.<\/td>\r\nMifepristone and Misoprostol versus Misoprostol alone for mid-trimester termination of pregnancy (14\u00a0- 21 weeks LMP): A randomized-controlled double-blinded trial<\/td>\r\n2011-2012<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
4.<\/td>\r\nThe acceptability and feasibility of reducing the need for in-clinic follow-up for first trimester medical abortion in Moldova and Uzbekistan<\/td>\r\n2010-2011<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
5.<\/td>\r\nUptake and acceptability of home-use of medical abortion<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
6.<\/td>\r\nMifepristone and Misoprostol versus Misoprostol alone for mid-trimester termination of pregnancy(14-21weeks)<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
7.<\/td>\r\nA randomized study of sublingual and buccal misoprostol administration following mifepristone 200 mg for abortion up to 63 days gestation<\/td>\r\n2007-2008<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
8.<\/td>\r\nSublingual misoprostol following mifepristone 200 mg for abortion up to 63 days gestation<\/td>\r\n\u00a02007<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
9.<\/td>\r\nMisoprostol for treatment of incomplete abortion<\/td>\r\n\u00a02005<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
10.<\/td>\r\nAcceptability and feasibility of medical abortion in law resources settings<\/td>\r\n\u00a02004<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n "},"excerpt":{"rendered":"","protected":false,"raw":""},"author":2,"featured_media":0,"parent":883,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-text.php","meta":{"_acf_changed":false,"_ru_post_content":"\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
<\/td>\r\n\u00a0\u041d\u0430\u0437\u0432\u0430\u043d\u0438\u0435<\/strong><\/td>\r\n\u00a0\u041f\u0435\u0440\u0438\u043e\u0434<\/strong><\/td>\r\n\u00a0\u0414\u043e\u043d\u043e\u0440, \u0411\u044e\u0434\u0436\u0435\u0442 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f<\/strong><\/td>\r\n<\/tr>\r\n
1.<\/td>\r\n\u041c\u0435\u0434\u0438\u043a\u0430\u043c\u0435\u043d\u0442\u043e\u0437\u043d\u044b\u0439 \u0430\u0431\u043e\u0440\u0442 \u043f\u043e\u0441\u0440\u0435\u0434\u0441\u0442\u0432\u043e\u043c \u0442\u0435\u043b\u0435\u043c\u0435\u0434\u0438\u0446\u0438\u043d\u044b \u0434\u043b\u044f \u0436\u0435\u043d\u0449\u0438\u043d \u0438 \u043f\u043e\u0434\u0440\u043e\u0441\u0442\u043a\u043e\u0432 \u0438\u0437 \u0441\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043c\u0435\u0441\u0442\u043d\u043e\u0441\u0442\u0438 \u041c\u043e\u043b\u0434\u043e\u0432\u044b: \u0443\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u0438\u0435 \u0431\u0430\u0440\u044c\u0435\u0440\u043e\u0432 \u043f\u0440\u0438 \u043f\u043e\u043c\u043e\u0449\u0438 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0439<\/a><\/td>\r\n2019-2021<\/td>\r\nGrand Challenges Canada \u2013 The OPTions Initiative<\/a><\/td>\r\n<\/tr>\r\n
2.<\/td>\r\n\u0423\u043f\u0440\u043e\u0449\u0435\u043d\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u043a\u0430\u043c\u0435\u043d\u0442\u043e\u0437\u043d\u044b\u0439 \u0430\u0431\u043e\u0440\u0442: \u0434\u0435\u043c\u043e\u043d\u0441\u0442\u0440\u0430\u0446\u0438\u044f \u043f\u0438\u043b\u043e\u0442\u043d\u043e\u0433\u043e \u043f\u0440\u043e\u0435\u043a\u0442\u0430<\/a><\/td>\r\n2015-2016<\/td>\r\nGynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
3.<\/td>\r\n\u041c\u0438\u0444\u0435\u043f\u0440\u0438\u0441\u0442\u043e\u043d \u0438 \u041c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b \u0432 \u0441\u0440\u0430\u0432\u043d\u0435\u043d\u0438\u0435 \u0441 \u041c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b\u043e\u043c \u0442\u043e\u043b\u044c\u043a\u043e \u0434\u043b\u044f \u043f\u0440\u0435\u0440\u044b\u0432\u0430\u043d\u0438\u044f \u0431\u0435\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0432\u043e \u0432\u0442\u043e\u0440\u043e\u043c \u0442\u0440\u0438\u043c\u0435\u0441\u0442\u0440\u0435 (14-21 \u043d\u0435\u0434\u0435\u043b\u044c): \u0440\u0430\u043d\u0434\u043e\u043c\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0435 \u043a\u043e\u043d\u0442\u0440\u043e\u043b\u044c\u043d\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435<\/td>\r\n2011-2012<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
4.<\/td>\r\n\u041f\u0440\u0438\u0435\u043c\u043b\u0435\u043c\u043e\u0441\u0442\u044c \u0438 \u0432\u044b\u043f\u043e\u043b\u043d\u0438\u043c\u043e\u0441\u0442\u044c \u0443\u043c\u0435\u043d\u044c\u0448\u0435\u043d\u0438\u044f \u043f\u043e\u0442\u0440\u0435\u0431\u043d\u043e\u0441\u0442\u0438 \u0432 \u043f\u043e\u0441\u0442-\u0430\u0431\u043e\u0440\u0442\u043d\u043e\u043c \u043d\u0430\u0431\u043b\u044e\u0434\u0435\u043d\u0438\u0435 \u0432 \u043a\u043b\u0438\u043d\u0438\u043a\u0435 \u0432 \u043f\u0435\u0440\u0432\u043e\u043c \u0442\u0440\u0438\u043c\u0435\u0441\u0442\u0440\u0435 \u043c\u0435\u0434\u0438\u043a\u0430\u043c\u0435\u043d\u0442\u043e\u0437\u043d\u043e\u0433\u043e \u0430\u0431\u043e\u0440\u0442\u0430 \u0432 \u041c\u043e\u043b\u0434\u043e\u0432\u0435 \u0438 \u0423\u0437\u0431\u0435\u043a\u0438\u0441\u0442\u0430\u043d\u0435<\/td>\r\n2010-2011<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
5.<\/td>\r\n\u0410\u0441\u0441\u0438\u043c\u0438\u043b\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0435 \u0438 \u043f\u0440\u0438\u0435\u043c\u043b\u0435\u043c\u043e\u0441\u0442\u044c \u0434\u043e\u043c\u0430\u0448\u043d\u0435\u0433\u043e \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u043c\u0435\u0434\u0438\u043a\u0430\u043c\u0435\u043d\u0442\u043e\u0437\u043d\u043e\u0433\u043e \u0430\u0431\u043e\u0440\u0442\u0430<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
6.<\/td>\r\n\u041c\u0438\u0444\u0435\u043f\u0440\u0438\u0441\u0442\u043e\u043d \u0438 \u041c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b \u0432 \u0441\u0440\u0430\u0432\u043d\u0435\u043d\u0438\u0435 \u0441 \u041c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b\u043e\u043c \u0442\u043e\u043b\u044c\u043a\u043e \u0434\u043b\u044f \u043f\u0440\u0435\u0440\u044b\u0432\u0430\u043d\u0438\u044f \u0431\u0435\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0432\u043e \u0432\u0442\u043e\u0440\u043e\u043c \u0442\u0440\u0438\u043c\u0435\u0441\u0442\u0440\u0435 (14-21 \u043d\u0435\u0434\u0435\u043b\u044c)<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
7.<\/td>\r\n\u0420\u0430\u043d\u0434\u043e\u043c\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 \u0441\u0443\u0431\u043b\u0438\u043d\u0433\u0432\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u0438 \u0431\u0443\u043a\u043a\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u0432\u0432\u0435\u0434\u0435\u043d\u0438\u044f \u043c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b\u0430 \u0441\u043b\u0435\u0434\u0443\u0435\u043c\u044b\u0439 \u043c\u0438\u0444\u0435\u043f\u0440\u0438\u0441\u0442\u043e\u043d\u043e\u043c 200 \u043c\u0433 \u0434\u043b\u044f \u043f\u0440\u0435\u0440\u044b\u0432\u0430\u043d\u0438\u044f \u0431\u0435\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0434\u043e 63 \u0434\u043d\u0435\u0439 \u043f\u0435\u0440\u0438\u043e\u0434\u0430<\/td>\r\n2007-2008<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
8.<\/td>\r\n\u0421\u0443\u0431\u043b\u0438\u043d\u0433\u0432\u0430\u043b\u044c\u043d\u043e \u043c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b \u0441\u043b\u0435\u0434\u0443\u0435\u043c\u044b\u0439 \u043c\u0438\u0444\u0435\u043f\u0440\u0438\u0441\u0442\u043e\u043d\u0430\u043c 200 \u043c\u0433 \u0434\u043b\u044f \u043f\u0440\u0435\u0440\u044b\u0432\u0430\u043d\u0438\u044f \u0431\u0435\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0434\u043e 63 \u0434\u043d\u0435\u0439 \u043f\u0435\u0440\u0438\u043e\u0434\u0430 \u0431\u0435\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0441\u0442\u0438<\/td>\r\n\u00a02007<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
9.<\/td>\r\n\u041c\u0438\u0437\u043e\u043f\u0440\u043e\u0441\u0442\u043e\u043b \u0434\u043b\u044f \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u043d\u0435\u043f\u043e\u043b\u043d\u043e\u0433\u043e \u0430\u0431\u043e\u0440\u0442\u0430<\/td>\r\n\u00a02005<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
10.<\/td>\r\n\u041f\u0440\u0438\u0435\u043c\u043b\u0435\u043c\u043e\u0441\u0442\u044c \u0438 \u043e\u0441\u0443\u0449\u0435\u0441\u0442\u0432\u0438\u043c\u043e\u0441\u0442\u044c \u043c\u0435\u0434\u0438\u043a\u0430\u043c\u0435\u043d\u0442\u043e\u0437\u043d\u043e\u0433\u043e \u0430\u0431\u043e\u0440\u0442\u0430 \u0432 \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0442\u0435\u043b\u044c\u043d\u044b\u0445 \u0440\u0435\u0441\u0443\u0440\u0441\u0430\u0445<\/td>\r\n\u00a02004<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n ","_ru_post_name":"studii-clinice","_ru_post_excerpt":"","_ru_post_title":"\u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f","_en_post_content":"\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
<\/td>\r\nTitle<\/strong><\/td>\r\n\u00a0Period<\/strong><\/td>\r\n\u00a0Donor, Study Budget<\/strong><\/td>\r\n<\/tr>\r\n
1.<\/td>\r\nMedical abortion via telemedicine for women and adolescents in rural Moldova: breaking barriers with technology, Telemedicine abortion for women and girls in rural Moldova<\/a><\/td>\r\n2019-2021\r\n<\/strong><\/td>\r\nGrand Challenges Canada \u2013 The OPTions Initiative<\/a><\/td>\r\n<\/tr>\r\n
2.<\/td>\r\nSimplified medical abortion: a pilot demonstration project<\/a><\/td>\r\n2015-2016<\/td>\r\nGynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
3.<\/td>\r\nMifepristone and Misoprostol versus Misoprostol alone for mid-trimester termination of pregnancy (14\u00a0- 21 weeks LMP): A randomized-controlled double-blinded trial<\/td>\r\n2011-2012<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
4.<\/td>\r\nThe acceptability and feasibility of reducing the need for in-clinic follow-up for first trimester medical abortion in Moldova and Uzbekistan<\/td>\r\n2010-2011<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
5.<\/td>\r\nUptake and acceptability of home-use of medical abortion<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
6.<\/td>\r\nMifepristone and Misoprostol versus Misoprostol alone for mid-trimester termination of pregnancy(14-21weeks)<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
7.<\/td>\r\nA randomized study of sublingual and buccal misoprostol administration following mifepristone 200 mg for abortion up to 63 days gestation<\/td>\r\n2007-2008<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
8.<\/td>\r\nSublingual misoprostol following mifepristone 200 mg for abortion up to 63 days gestation<\/td>\r\n\u00a02007<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
9.<\/td>\r\nMisoprostol for treatment of incomplete abortion<\/td>\r\n\u00a02005<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
10.<\/td>\r\nAcceptability and feasibility of medical abortion in law resources settings<\/td>\r\n\u00a02004<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n ","_en_post_name":"studii-clinice","_en_post_excerpt":"","_en_post_title":"Clinical studies","_ro_post_content":" \r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
<\/td>\r\n\u00a0Titlul<\/strong><\/td>\r\n\u00a0Durata<\/strong><\/td>\r\n\u00a0Donatori, Bugetul studiului<\/strong><\/td>\r\n<\/tr>\r\n
1.<\/td>\r\nAvortul medicamentos prin telemedicin\u0103 pentru femei \u0219i adolescen\u021bi din mediul rural din Moldova: \u00eenl\u0103turarea barierelor cu ajutorul tehnologiei<\/a><\/td>\r\n2019-2021<\/td>\r\nGrand Challenges Canada \u2013 The OPTions Initiative<\/a><\/td>\r\n<\/tr>\r\n
2.<\/td>\r\nAvortul medicamentos simplificat: Proiect-pilot demonstrativ<\/a><\/td>\r\n2015-2016<\/td>\r\nGynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
3.<\/td>\r\nMifepriston \u015fi Misoprostol \u00een compara\u0163ie numai cu Misoprostol pentru \u00eentreruperea sarcinii \u00een trimestrul doi (14 \u2013 21 s\u0103pt\u0103m\u00e2ni): Studiu randomizat de control<\/td>\r\n2011-2012<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
4.<\/td>\r\nAcceptabilitatea \u015fi fezabilitatea reducerii necesit\u0103\u0163ii de supraveghere \u00een clinic\u0103 a avortului medicamentos \u00een primul trimestru de sarcin\u0103 \u00een Moldova \u015fi Uzbekistan<\/td>\r\n2010-2011<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
5.<\/td>\r\nAsimilarea \u015fi acceptabilitatea avortului medicamentos la domiciliu<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
6.<\/td>\r\nMifepriston \u015fi Misoprostol \u00een compara\u0163ie numai cu Misoprostol pentru \u00eentreruperea sarcinii \u00een trimestrul doi (14-21s\u0103pt\u0103m\u00eeni)<\/td>\r\n2009<\/td>\r\n\u00a0Gynuity Health Projects<\/a>,<\/td>\r\n<\/tr>\r\n
7.<\/td>\r\nUn studiu randomizat al administr\u0103rii misoprostolului sublingual si oral urmat de administrarea mifepristonului de 200 mg pentru avortul la termenul de gesta\u0163ie p\u00e2n\u0103 la 63 zile<\/td>\r\n2007-2008<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
8.<\/td>\r\nAdministrarea misoprostolului sublingual urmat de mifepriston 200 mg pentru avortul la termenul de gesta\u0163ie p\u00e2n\u0103 la 63 zile<\/td>\r\n\u00a02007<\/td>\r\n\u00a0Gynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
9.<\/td>\r\nMisoprostolul \u00een tratamentul avortului incomplet<\/td>\r\n\u00a02005<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n
10.<\/td>\r\nAcceptabilitatea \u015fi fezabilitatea avortului medicamentos \u00een adaptarea legisla\u0163iei<\/td>\r\n\u00a02004<\/td>\r\nGynuity Health Projects<\/a><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n ","_ro_post_name":"studii-clinice","_ro_post_excerpt":"","_ro_post_title":"Studii clinice","edit_language":"en","footnotes":""},"class_list":["post-975","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nStudii clinice - Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Studii clinice - Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive\" \/>\n<meta property=\"og:description\" content=\"Title \u00a0Period \u00a0Donor, Study Budget 1. Medical abortion via telemedicine for women and adolescents in rural Moldova: breaking barriers with technology, Telemedicine abortion for women and girls in rural Moldova 2019-2021 Grand Challenges Canada \u2013 The OPTions Initiative 2. Simplified medical abortion: a pilot demonstration project 2015-2016 Gynuity Health Projects, 3. Mifepristone and Misoprostol versus […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/\" \/>\n<meta property=\"og:site_name\" content=\"Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-03T09:26:59+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/\",\"url\":\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/\",\"name\":\"Studii clinice - Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive\",\"isPartOf\":{\"@id\":\"https:\/\/cidsr.md\/#website\"},\"datePublished\":\"2023-10-20T11:18:33+00:00\",\"dateModified\":\"2024-04-03T09:26:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cidsr.md\/portofolio\/studii-clinice\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0413\u043b\u0430\u0432\u043d\u0430\u044f \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u0430\",\"item\":\"https:\/\/new.cidsr.md\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portofoliu\",\"item\":\"https:\/\/cidsr.md\/portofolio\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Studii clinice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cidsr.md\/#website\",\"url\":\"https:\/\/cidsr.md\/\",\"name\":\"Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive\",\"description\":\"Promov\u0103m s\u0103n\u0103tatea \u0219i drepturile sexuale \u0219i reproductive!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cidsr.md\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Studii clinice - Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cidsr.md\/portofolio\/studii-clinice\/","og_locale":"en_US","og_type":"article","og_title":"Studii clinice - Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive","og_description":"Title \u00a0Period \u00a0Donor, Study Budget 1. Medical abortion via telemedicine for women and adolescents in rural Moldova: breaking barriers with technology, Telemedicine abortion for women and girls in rural Moldova 2019-2021 Grand Challenges Canada \u2013 The OPTions Initiative 2. Simplified medical abortion: a pilot demonstration project 2015-2016 Gynuity Health Projects, 3. Mifepristone and Misoprostol versus […]","og_url":"https:\/\/cidsr.md\/portofolio\/studii-clinice\/","og_site_name":"Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive","article_modified_time":"2024-04-03T09:26:59+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cidsr.md\/portofolio\/studii-clinice\/","url":"https:\/\/cidsr.md\/portofolio\/studii-clinice\/","name":"Studii clinice - Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive","isPartOf":{"@id":"https:\/\/cidsr.md\/#website"},"datePublished":"2023-10-20T11:18:33+00:00","dateModified":"2024-04-03T09:26:59+00:00","breadcrumb":{"@id":"https:\/\/cidsr.md\/portofolio\/studii-clinice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cidsr.md\/portofolio\/studii-clinice\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cidsr.md\/portofolio\/studii-clinice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0413\u043b\u0430\u0432\u043d\u0430\u044f \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u0430","item":"https:\/\/new.cidsr.md\/"},{"@type":"ListItem","position":2,"name":"Portofoliu","item":"https:\/\/cidsr.md\/portofolio\/"},{"@type":"ListItem","position":3,"name":"Studii clinice"}]},{"@type":"WebSite","@id":"https:\/\/cidsr.md\/#website","url":"https:\/\/cidsr.md\/","name":"Centrul de Instruire \u00een Domeniul S\u0103n\u0103t\u0103\u0163ii Reproductive","description":"Promov\u0103m s\u0103n\u0103tatea \u0219i drepturile sexuale \u0219i reproductive!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cidsr.md\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/pages\/975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/comments?post=975"}],"version-history":[{"count":11,"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/pages\/975\/revisions"}],"predecessor-version":[{"id":11909,"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/pages\/975\/revisions\/11909"}],"up":[{"embeddable":true,"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/pages\/883"}],"wp:attachment":[{"href":"https:\/\/cidsr.md\/en\/wp-json\/wp\/v2\/media?parent=975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}